PetVivo Holdings Inc Total Assets
PetVivo Holdings Inc total assets. Based on the latest financial reports, PetVivo Holdings Inc (PETV) holds total assets worth $6.89 Million USD as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see PetVivo Holdings Inc (PETV) total market value for the company's overall valuation and market capitalisation.
Total Assets of PetVivo Holdings Inc (2011–2025)
Total assets of PetVivo Holdings Inc from 2011 to 2025. This chart illustrates how PetVivo Holdings Inc's total assets have evolved over time, based on quarterly financial data. See PETV stock price and chart for real-time trading data and today's change.
PetVivo Holdings Inc - Asset Composition Analysis
PetVivo Holdings Inc Total Assets Breakdown (March 2025)
PetVivo Holdings Inc total assets breakdown as of March 2025. PetVivo Holdings Inc's total assets of $6.89 Million consist of 60.1% current assets and 39.9% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 2.4% |
| Accounts Receivable | $4.46 Million | 47.8% |
| Inventory | $323.50K | 3.5% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $1.97 Million | 21.1% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2011–2025)
This chart illustrates how PetVivo Holdings Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore PETV net working capital ratio to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: PetVivo Holdings Inc's current assets represent 60.1% of total assets in 2025, a decrease from 100.0% in 2011.
- Cash Position: Cash and equivalents constituted 2.4% of total assets in 2025, down from 28.5% in 2011.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 21.0% of total assets, an increase from 0.0% in 2011.
- Asset Diversification: The largest asset category is accounts receivable at 47.8% of total assets.
PetVivo Holdings Inc Competitors by Total Assets
Key competitors of PetVivo Holdings Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥5.03 Billion |
|
BMC Medical Co. Ltd. A
SHE:301367
|
China | CN¥3.59 Billion |
|
SS Innovations International Inc. Common Stock
NASDAQ:SSII
|
USA | $96.98 Million |
|
Emvision Medical Devices Ltd
AU:EMV
|
Australia | AU$24.94 Million |
|
Sequana Medical NV
BR:SEQUA
|
Belgium | €14.57 Million |
|
Hironic Co. Ltd
KQ:149980
|
Korea | ₩80.01 Billion |
|
DRGEM Corporation
KQ:263690
|
Korea | ₩131.65 Billion |
PetVivo Holdings Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.41 | 0.81 | 0.13 |
| Quick Ratio | 1.24 | 0.46 | 0.13 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $1.28 Million | $-211.12K | $-1.97 Million |
PetVivo Holdings Inc - Advanced Valuation Insights
This section examines the relationship between PetVivo Holdings Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 11.36 |
| Latest Market Cap to Assets Ratio | 3.77 |
| Asset Growth Rate (YoY) | 199.8% |
| Total Assets | $9.34 Million |
| Market Capitalization | $35.24 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values PetVivo Holdings Inc's assets at a significant premium (3.77x), suggesting investors see substantial growth potential or unique competitive advantages.
Rapid Asset Growth: PetVivo Holdings Inc's assets grew by 199.8% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for PetVivo Holdings Inc (2011–2025)
The table below shows the annual total assets of PetVivo Holdings Inc from 2011 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-03-31 | $9.34 Million | +199.79% |
| 2024-03-31 | $3.12 Million | +27.73% |
| 2023-03-31 | $2.44 Million | -67.16% |
| 2022-03-31 | $7.43 Million | +789.24% |
| 2021-03-31 | $835.25K | +59.85% |
| 2020-03-31 | $522.52K | -24.40% |
| 2019-03-31 | $691.15K | -55.92% |
| 2018-03-31 | $1.57 Million | -17.35% |
| 2017-03-31 | $1.90 Million | -88.63% |
| 2016-03-31 | $16.69 Million | +2087.74% |
| 2015-03-31 | $762.86K | +330.17% |
| 2014-03-31 | $177.34K | +146.47% |
| 2013-03-31 | $71.95K | +5221.89% |
| 2012-03-31 | $1.35K | -63.84% |
| 2011-03-31 | $3.74K | -- |
About PetVivo Holdings Inc
PetVivo Holdings, Inc., a biomedical device company, manufactures, commercializes, and licenses medical devices and therapeutics for animals in the United States. The company's lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. It also provides therapeutic devices for … Read more